Selective binding of soluble Aβ1-40 and Aβ1-42 to a subset of senile plaques

American Journal of Pathology

Volumn 148, Issue 6, 1996, Pages 1749-1756

  Prior, Reinhard ^a   D'Urso, Donatella ^a   Frank, Rainer ^b   Prikulis, Ingrid ^a   Cleven, Silke ^a   Ihl, Ralf ^a   Pavlakovic, Goran ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; PROTEOHEPARAN SULFATE;

AGED; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; QUANTITATIVE DIAGNOSIS; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; BRAIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 0029975595     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Selkoe DJ: Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994, 10:373-403
2. Maury CPJ: Molecular pathogenesis of β-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Lab Invest 1995, 72:4-16
3. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325:733-736
4. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Savis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D: Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 1992, 359:325-327
5. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB: Characterization of β-amyloid peptide from human cerebrospinal fluid. J Neurochem 1993, 61:1965-1968
6. Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto S, Frangione B: Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem J 1995, 306:599-604
7. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472
8. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak VM, Goldgaber D, Roses AD: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993, 90:9649-9653
9. Strittmatter WJ, Saunders AM, Schmechel D, Pericak VM, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993, 90:1977-1981
10. Richey PL, Siedlak SL, Smith MA, Perry G: Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. Biochem Biophys Res Commun 1995, 208:657-663
11. Naeslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlstroem AR, Bogdanovic N, Gandy SE, Lannfelt L, Terenius L, Nordstedt C: Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron 1995, 15:219-228
12. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D: Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad USA 1993, 90:8098-8102
13. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE: Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994, 269:23403-23406
14. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG: An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A β-amyloid in rat brain. Neuron 1994, 12:219-234
15. Buee L, Ding W, Delacourte A, Fillit H: Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res 1993, 601: 154-163
16. Snow AD, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S, Hassell H, Wight TN: The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 1988, 133:456-463
17. Su JH, Cummings BJ, Cotman CW: Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 1992, 51:801-813
18. Gupta-Bansal R, Frederickson RC, Brunden KR: Proteoglycan-mediated inhibition of A β proteolysis: a potential cause of senile plaque accumulation. J Biol Chem 1995, 270:18666-18671
19. Jarrett JT, Berger EP, Lansbury PJ: The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693-4697
20. Mann DMA, Younis N, Jones D, Stoddart RW: The time course of pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4. Neurodegeneration 1992, 1:201-215
21. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina M, Ihara Y: Visualization of Aβ β 42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43), Neuron 199, 13:45-53
22. Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y: Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 1995, 37:294-299
23. Frank R, Gausepohl H: Continuous flow peptide synthesis. Modern Methods in Protein Chemistry, vol 3. Edited by H Tschesche. Berlin, De Gruyter, 1988, pp 42-60
24. Carpino LA, Han GY: The 9-fluoronylmethoxycarbonyl amino protecting group. J Org Chem 1972, 37:3404-3409
25. Coste J, Le-Nguyen D, Castro B: PyBOP: a new peptide coupling reagent devoid of toxic by-product. Tetrahedron Lett 1990, 31:205-208
26. Kim KS, Miller DL, Sapienza VJ, Chen CM, Bai C, Grundke-Iqbal I, Currie JR, Wiesniewski HM: Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 1988, 2:121-130
27. Prior R, D'Urso D, Frank R, Prikulis I, Pavlakovic G: Experimental deposition of Alzheimer amyloid β-protein in canine leptomeningeal vessels. Neuroreport 1995, 6:1747-1751
28. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Menschen A, Yates J, Cotman C, Glabe C: Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 1992, 267:546-554
29. Suzuki N, Cheung TT, Cai X, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG: An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 1994, 264:1336-1340
30. Prelli F, Castano E, Glenner GG, Frangione B: Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 1988, 51:648-651
31. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ: β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proc Natl Acad Sci USA 1993, 90:10836-10840
32. Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y: High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994, 145:452-460
33. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, Suzuki N, Younkin SG: Amyloid β protein (Aβ) in Alzheimer's disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J Biol Chem 1995, 270:7013-7016
34. Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW: Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 1992, 89: 5462-5466